buthionine sulfoximine and glutathione synthesis - an overview resistant human breast cancer cells Buthionine Sulphoximine | New Drug
Buthionine Sulphoximine New Drug Approvals L Buthionine sulfoximine = 97 TLC 83730 53 4 Sigma Aldrich Buthionine sulfoximine, CAS 83730 53 4, 97% (TLC) 500 mg buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S Transferase Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () Preclinical evaluation of azathioprine plus
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


